2m 2m 2m 2m 2m 2m 2m
Starling Oncol (STLN)
NASDAQ
$6.76-$0.16 (-2.24%)
Price as of Oct 23, 2026 6:06 PM EDT- $704.2MMarket Cap
- N/A1-Year Change
- Medical Care FacilitiesIndustry
Starling Oncol (STLN)
$6.76-$0.16 (-2.24%)
STLN | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $6.91 | ||
Change | +$0.08 (+1.17%) | ||
Open | $6.75 | ||
High | $6.96 | ||
Low | $6.69 | ||
Previous Close | $6.83 | ||
Volume | 871,697 | ||
30-Day Average Volume | 1,174,258 | ||
1-Week Change | 0.00% | ||
1-Month Change | -1.99% | ||
1-Year Change | N/A | ||
3-Year Change | N/A | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 101.9M | ||
Total Assets | $178.2M | ||
Market Cap | $704.2M | ||
Enterprise Value | $743.0M | ||
Period: QTR TTM FY | |||
Revenue | $58.8M | ||
Net Income | -$9.8M | ||
Free Cash Flow | $11.0M | ||
EBIT | -$9.8M | ||
EBITDA | -$8.0M | ||
Net Working Capital | $34.1M | ||
EPS | -$0.08 | ||
Enterprise Value/EBITDA | -93 | ||
Enterprise Value/Revenue | 13 | ||
P/B | -28 | ||
P/E | -86 | ||
PEG | 0 | ||
Price/Free Cash Flow | 64 | ||
Price/Operating Cash Flow | 59 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue